The first U.S. trial for a coronavirus treatment has started

The National Institutes of Health (NIH) confirmed on Tuesday that the first U.S. clinical trial for a coronavirus treatment has launched at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. The experimental therapy is biotech giant Gilead's remdesivir, an antiviral with the potential to treat a host of pathogens—including COVID-19, the disease caused by the new, novel coronavirus strain.